Incyte Partners With Penn on Cancer Immunotherapy Research – Genetic Engineering & Biotechnology News
Business Wire |
Incyte Partners With Penn on Cancer Immunotherapy Research
Genetic Engineering & Biotechnology News Incyte said today it will partner with the Abramson Cancer Center at the University of Pennsylvania on research into cancer biology and immunotherapy. Through the collaboration, whose value was not disclosed, Penn investigators will study novel … Incyte Corporation: Incyte Announces Oncology Research Alliance with the Abramson Cancer Center at the University …The Wall Street Transcript |
The Scientist |
Smallest Cas9 Ortholog Reported
The Scientist The researchers packaged CRISPR-CjCas9 into an adeno-associated viral (AAV) vector, which they then injected into the muscles and eyes of mice. To demonstrate CjCas9’s capabilities, they used the system to modify a mouse gene linked to blindness. |
USgamer |
Mass Effect Andromeda: How Well Does it Balance Action and RPG?
USgamer Are there any games that you know you’d very likely enjoy playing, but there’s just been something about them that put you off trying them out? That’s the Mass Effect series and me. The first game really caught my interest, but what I perceived as its … |
MIT Technology Review |
The Download, Feb 23, 2017: Immunotherapy Upgrade, Tesla’s Next Challenge, and Locating the Dark Web
MIT Technology Review The Download, Feb 23, 2017: Immunotherapy Upgrade, Tesla’s Next Challenge, and Locating the Dark Web. The most fascinating and important news in technology and innovation delivered straight to your inbox, every day. by Jamie Condliffe; February 23, … |
|
World-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board
Yahoo Finance “Dr. Cutler is world renowned for his contributions to innovations within the stem cell transplantation industry to drive potential treatments in cancer and many other medical conditions,” said Dr. Shai Yarkoni, Cellect’s CEO. “We look forward to … |